SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-004259
Filing Date
2024-02-14
Accepted
2024-02-14 21:53:50
Documents
1
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 5 rdgdoc.html 5  
1 FORM 5 rdgdoc.xml 5 3171
  Complete submission text file 0001437749-24-004259.txt   4894
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 787 SEVENTH AVENUE, 48TH FLOOR NEW YORK NY 10019
Business Address
Power Sean A (Reporting) CIK: 0001538845 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32639 | Film No.: 24641859